The abrB gene of Bacillus subtilis is believed to encode a repressor that controls the expression of genes involved in starvation-induced processes such as sporulation and the production of antibiotics and degradative enzymes. Two such genes, spoVG, a sporulation gene of B. subtilis, and tycA, which encodes tyrocidine synthetase I of the tyrocidine biosynthetic pathway in Bacilus brevis, are negatively regulated by abrB in B. subtilis. To examine the role of abrB in the repression of gene transcription, the AbrB protein was purified and then tested for its ability to bind to spoVG and tycA promoter DNA. In a gel mobility shift experiment, AbrB was found to bind to a DNA fragment containing the sequence from -95 to +61 of spoVG. AbrB protein exhibited reduced affinity for DNA of two mutant forms of the spoVG promoter that had been shown to be insensitive to abrB-dependent repression in vivo. These studies showed that an upstream A+T-rich sequence from -37 to -95 was required for optimal AbrB binding. AbrB protein was also observed to bind to the tycA gene within a region between the transcription start site and the tycA coding sequence as well as to a region containing the putative tycA promoter. These fridings reinforce the hypothesis that AbrB represses gene expression through its direct interaction with the transcription initiation regions of genes under its control.
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When cells of the spore-forming bacterium Bacillus subtilis encounter a nutritionally poor environment, characteristic of a culture that has entered stationary phase of growth, genes that function in such diverse processes as the production of degradative enzymes and antibiotics, competence development, and sporulation are induced through mechanisms that operate at the transcriptional level (1) (2) (3) (4) (5) . The transcription of many stationary phase-induced genes requires the product of the spoOA gene (1) (2) (3) (4) (5) . The amino acid sequence of the spoOA gene product shows homology with the activator class of the two-component regulatory proteins, which supports the hypothesis that spoOA is part of a pathway that senses the nutritional environment (6, 7) . One of the primary functions of SpoOA is to repress the transcription of the abrB gene, whose product is believed to be a negative regulator of stationary phase-induced genes (8, 9) . The amino acid sequence of the abrB product shares homology with the DNAbinding regions of known transcriptional regulatory proteins, suggesting that AbrB negatively affects transcription through a direct interaction with promoter DNA (9) . The current model of spoOA and abrB function is in keeping with earlier studies that showed that abrB is the site of mutations that partially suppress the pleiotropy of spoOA mutations (10) (11) (12) (13) . To repress abrB transcription is not the sole function of spoOA since a spoOA abrB double mutant is unable to sporulate.
Two genes that are subject to abrB-dependent repression are spoVG (14, 15) , a sporulation gene, and tycA, a Bacillus brevis gene that encodes tyrocidine synthetase I, an enzyme of the biosynthetic pathway for the peptide antibiotic tyrocidine (3, 16) . Both are transcriptionally induced in B. subtilis under conditions of nutritional depletion but differ with respect to their requirements for transcription initiation and regulation. The initiation of spoVG transcription is carried out by the minor (0.H) form of RNA polymerase holoenzyme (17, 18) , whereas the tycA promoter is recognized by the major (0.A) holoenzyme (3) . Unlike tycA, the transcription of spoVG is induced, through an unknown mechanism, by the treatment of cells with the sporulation-inducing agent decoyinine (8), a drug that causes a rapid decrease in the intracellular concentration of GTP (19) . Despite these differences, transcription from each promoter requires the product of the spoOA gene, a requirement that is overcome by mutations in abrB (3, 20) . The finding that a mutation upstream of the spoVG promoter within an A+T-rich region (upstream activating sequence, UAS) also overcomes the requirement for spoOA suggests that abrB-dependent control acts near the spoVG transcription initiation region (8) . In this report, we describe the purification of the abrB product and present evidence that the AbrB protein interacts directly with DNA that contains the promoter of either tycA or spoVG.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. Escherichia coli strain AG1574 [araD139 A(ara leu)7697 AlacX74 galU,K hsr-m+ strA recA56 srL] was described previously (4) . E. coli strain K-38 (HfrCA, ref. 20) was obtained from A. Harker (Oklahoma State University) and S. Tabor (Harvard University Medical School). E. coli strain XL1-blue {recAl endAl gyrA96 thi hsdRJ7 (rk-mk-) supE44 relAl lac-[F' proAB lacP ZAM15 TnWO (tet9)]} was obtained from Stratagene and was used as a host for bacteriophage M13. Plasmid pTV20 was obtained from P. Youngman (21) , and its construction and use in the molecular cloning ofB. subtilis DNA have been described previously (21) . Plasmid pZSP6-189 (22) contains a 217-base-pair (bp) fragment that bears the spoVG promoter region. Plasmids pZL207 (23) and p42/327 (8) are pZA327 (24) derivatives that contain a 157-bp HindIII-Sal I fragment of the spoVG and mutant spoVG42 promoters, respectively. Plasmid pZA217 (24) is a pZL205 (23) region on a 888-bp Pvu II-Xmn I fragment. Plasmids pGEM3 and pGEM4 were purchased from Promega Biotec. Plasmid pGP1-2 (25) , which carries a kanamycin-resistance determinant and the gene encoding 17 RNA polymerase, was obtained from A. Harker and S. Tabor. The T7 RNA polymerase gene is controlled by the A PL promoter and a plasmidencoded, heat-sensitive cI repressor (25) . Phage M13 cloning vectors mp9 (26) and um3O and um31 (International Biotechnologies) were used in the molecular cloning of DNA for nucleotide sequence analysis. DNA Manipulation. Plasmid DNA from E. coli cells was purified by using the method of Birnboim and Doly (27) with modifications (28) . Restriction enzymes and T4 DNA ligase were purchased from Bethesda Research Laboratories and Promega Biotec and were used according to protocols provided by the vendors. M13 recombinant phage clones were subject to nucleotide sequencing by using the method of Sanger et al. (29) .
AbrB Expression System. The plasmid pG3-516RH, a derivative of pGEM3, contains an EcoRI-HindIII fragment bearing the abrB coding sequence and ribosome binding site (see Fig. 1 ). The coding sequence lies downstream from a T7 phage promoter. This plasmid was introduced by transformation into a derivative of strain K-38 that carries pGP1-2. Transformants were grown at 30°C on LB medium containing ampicillin (25 ,ug/ml) and kanamycin (25 ,ug/ml). Individual transformants were grown in 2 ml of 2 x YT medium containing ampicillin and kanamycin at 30°C to late exponential phase of growth (OD595 = 1.5). The temperature was raised to 45°C to induce the synthesis of T7 RNA polymerase, and incubation was continued for 4 hr. The cells of each culture were collected by centrifugation, suspended in electrophoresis sample buffer (30) , boiled, and subjected to SDS/PAGE in a 15% polyacrylamide gel (30:1, acrylamide to N,N'-methylene-bisacrylamide) (30) . Proteins were visualized by staining the gel with Coomassie blue. Plasmid-encoded proteins were further examined by radiolabeling. This was accomplished by taking advantage of the resistance of T7 RNA polymerase to the antibiotic rifampicin (25) . Cultures of cells that carry both pG3-516RH and pGP1-2 were grown to late logarithmic phase and then simultaneously treated with rifampicin (200 ,ug/ml) and 35S-labeled methionine and cysteine (10 ,Ci; 1 Ci = 37 GBq; ICN). The cells were incubated 30 min, collected by centrifugation, and analyzed by PAGE as described above.
Purification of AbrB Protein. E. coli strain K-38/pGP1-2 cells bearing plasmid pG3-516RH were grown to OD6w = 1.5 at 30°C in 2 liters of2x YT with kanamycin and ampicillin (25 ,g/ml). The temperature was then raised to 45°C for 2-3 hr.
The cells were harvested by centrifugation, resuspended in 20 ml of G-50 buffer (20 mM Tris-HCI, pH 7.5/1 mM EDTA/1 mM dithiothreitol), and sonicated for a total of 4 min (four 1-min pulses between which the cells were incubated on ice for 1 min). The lysate was subjected to centrifugation in a Sorvall SA-600 rotor at 10,000 rpm for 10 min. Protein in the supernatant was subjected to fractionation with (NH4)2SO4 at 35% and 50o of saturation. The final supernatant was combined with (NH4)2SO4 to 60% of saturation and placed on ice overnight. The precipitate was collected by centrifugation and dissolved in G-50 buffer. The solution was applied to a gel-filtration Sephadex G-50 (Pharmacia) column (2 x 80 cm), and protein within the fractions was monitored by measuring OD280 and by SDS/PAGE. Fractions enriched for AbrB protein were applied to a Heparin-agarose affinity column (0.5 x 10 cm) that was equilibrated with G-50 buffer. Extensive washing with G-50 buffer resulted in the release of AbrB protein that was substantially pure as judged by SDS/PAGE analysis (see Fig. 3 ). The estimated recovery of the protein was 30-40%. Samples of AbrB protein were Iyophilized and stored at -80'C.
DNA-Binding Studies. Restriction endonuclease-cleaved spoVG DNA and lyophilized AbrB protein were dissolved in buffer A (31) (20 mM Tris HCl, pH 7.5/10 mM MgCI2/l mM EDTA/0.3 mM dithiothreitol/3% glycerol). Protein concentration was determined by the Bradford assay (32). The binding reaction mixtures contained AbrB protein pmol) and DNA (1 prnol) in 30 gl of buffer A and were incubated for 30 min at 250C. Two microliters of bromophenol blue in 15% glycerol was added to the reactions, which were then subjected to electrophoresis on a 6% polyacrylamide (30:1) gel. DNA was visualized by ethidium bromide staining and UV irradiation. Conditions for gel mobility shift assay involving tycA DNA are described in Fig. 6 .
RESULTS
A transposon insertion mutation in the abrB locus was isolated from a library of Tn917 insertions (33, 34) . The procedure developed by Youngman et al. (21) was used to isolate the DNA flanking the putative abrB: :Tn9I7 insertion. Plasmid p2OKR1 (Fig. la) contains 3-kilobases (kb) of chromosomal DNA containing part of the abrB gene, one-half of Tn917, and pBR322 DNA. A 1.9-kb Cla I fragment of p2OKR1 chromosomal sequences adjacent to the transposon was inserted into pGEM4, thus giving rise to plasmid pGC516R (Fig. lb) . A 0.7-kb EcoRI-HindIII fragment of pGC516R containing the end of Tn917 and flanking DNA was subjected to sequence analysis. It was discovered that the Tn917 insertion mutation was identical to that characterized by Perego et al. (9) , who found that the transposon had inserted between the promoter and the coding sequence of abrB. An open reading frame encoding a protein of 10,760 Da was identified whose sequence was identical to the abrB coding sequence (9) .
An expression plasmid (pGEM3) bearing a phage T7 promoter was utilized to express abrB in E. coli. Two pGEM3 derivatives were constructed. Plasmid pG3-516R (Fig. lb) contains the 1.9-kb Cla I fragment of p2OKR1 that bears the abrB coding sequence. Plasmid pG3-516RH (Fig. 1) contains the 0.7-kb EcoRI-HindIII fragment of pGC516R. Each plasmid was used to transform E. coli strain K-38/pGP1-2 (25) . A control strain contained pGC516R, which bears the abrB coding sequence in the opposite orientation with respect to the T7 promoter of pGEM3 (Fig. 1) . Cells of the plasmidbearing strains were grown in liquid culture and subjected to heat treatment to induce T7 promoter/abrB expression. Analysis of the T7 promoter/abrB plasmid-encoded proteins by PAGE revealed a prominent band corresponding to a protein of approximately 10 kDa (data not shown). This band was absent from the protein profiles of cells bearing either the parent pGEM3 vector or the plasmid-borne abrB sequence in the opposite orientation to that of the T7 promoter. The products of the plasmids were specifically radiolabeled in order to more precisely examine the proteins encoded by the abrB DNA. Only the products of the DNA transcribed by the rifampicin-resistant T7 RNA polymerase were radiolabeled in this procedure (25) . A product was observed in the extract of the pG3-516RH-bearing cells with the same molecular mass as the 10-kDa protein observed in the Coomassie blue-stained profile (Fig. 2) . Another protein was also detected, but the same species was observed in cells of the control strain containing the parent pGEM3 vector. Several proteins of molecular mass higher than the putative AbrB protein were produced in cells with plasmids containing the abrB insert DNA in the opposite orientation with respect to the T7 promoter. Since the 10-kDa protein was the only radiolabeled protein attributed to the T7 promoter/abrB sequences, this protein was identified as the product of the abrB coding sequence.
The AbrB protein was produced in the E. coli K-38 cells carrying pG3-516RH and purified by a procedure involving ammonium sulfate fractionation, gel filtration, and heparin affinity gel column chromatography (see Materials and Methods). Fig. 3 shows a SDS/PAGE profile of the final product that was used in the DNA-binding experiments. Gel mobility shift experiments were performed with the AbrB protein and spoVG promoter DNA. Plasmid pZSP6-189 was cleaved with EcoRI, HindIII, and Pvu II to generate a 182-bp Pvu IIHindIII fragment (fragment B in Fig. 4 Fig. 4 ) is a partial digestion product composed of fragments A and B. Samples of the restriction endonuclease-digested plasmids were combined with AbrB protein (13, 65 , and 130 pmol per pmol of DNA). The three low molecular weight DNA species (fragments A, B, and A-B) were observed in the polyacrylamide gel profile of the sample to which no protein was added (Fig. 4b) . Shifts in the positions of bands A and A-B were observed in the gel profiles of the samples that contained the AbrB protein, indicating that AbrB binds preferentially to the fragments containing spoVG DNA.
Experiments were undertaken to examine the binding affinity of AbrB for two mutant forms of the spoVG promoter that have been shown to be insensitive to abrB-dependent repression in vivo (ref. 8; D. Frisby and P.Z., unpublished results; ¶). One of these is the spoVG42 promoter, which bears a C to T transition at position -58 within the spoVG UAS (Fig. 5) . The other is a spoVG deletion derivative, spoVG217, which is lacking sequences from -37 to -95. In the experiment summarized in Fig. 4c, both was observed. When the spoVG42 promoter fragment was combined with spoVG2J7 DNA and AbrB protein, the two mutant promoter fragments were observed to bind AbrB with near equal affinity. Binding of AbrB to spoVG42 occurred at a concentration of protein that was 2-fold higher than that required for AbrB to interact with the wild-type spoVG promoter DNA. These results indicate that AbrB shows a higher affinity for the wild-type spoVG promoter than for either of its mutant derivatives. The protein was also tested for its ability to bind to the transcription initiation region of another abrB-controlled gene, tycA (Fig. 6) . The plasmid pGEM3-38 (3) contains the promoter region of tycA and the leader region that lies between the transcription start site and the beginning of the tycA coding sequence (3, 35) . pGEM3-38 DNA (600 ng) was cleaved with Pvu II and Hae II and combined with AbrB at concentrations of 25-125 ng per 30-1.d reaction mixture. Binding of AbrB to the DNA was observed to the 598-bp Pvu I-Hae II fragment containing sequences at +39 to a point 309 bp downstream within the leader region of tycA. At higher AbrB concentrations, the protein was observed to bind to the 231-bp fragment containing the promoter region of tycA between +38 and -193. The migration of the Hae II-Pvu I fragments of vector plasmid DNA in the polyacrylamide gel was not altered by the addition of the AbrB protein.
DISCUSSION
The abrB gene encodes a protein that is believed to function as a negative regulator of genes that are transcriptionally induced in cells that have entered stationary phase ofgrowth. A logical explanation for the observed effect of AbrB on gene expression is that the protein binds directly to the promoter and/or regulatory sequences of the genes that are under abrB-dependent negative control. The data presented here show that the abrB product binds to DNA near the transcription initiation region of both spoVG and tycA, although at different regions with respect to their transcription start sites. A region upstream of the spoVG sequence where RNA polymerase interacts is required for optimal AbrB binding. A mutation in this region, spoVG42 (located in the UAS) and a deletion mutation, spoVG2J7 (which removes the UAS) both render spoVG transcription insensitive to AbrB-dependent control. In vitro, AbrB protein exhibits less affinity for the DNA of the two mutant promoters than to the wild-type promoter. Though binding to the two mutant promoter fragments is observed, it is not known if this is a result of nonspecific binding of AbrB. The data suggest that there may be more than one binding site in the spoVG promoter region or that AbrB binds as a multimer, as evidenced by the appearance of partial complexes (Fig. 4b, lane 3 ) that migrate to positions between those of the unbound DNA (Fig. 4b,  lane 2) and the slowest migrating AbrB-DNA band (Fig. 4b,  lane 5) .
Binding of AbrB to tycA was also demonstrated in gel mobility shift assays. In this case, the protein bound to a region at least 37 bp downstream from the transcriptional start site and upstream from the tycA coding sequence. At higher protein concentrations, AbrB was observed to bind to the DNA containing the putative promoter of tycA. The exact location of the AbrB binding regions in both the spoVG and tycA promoters awaits more precise methods for localizing protein-DNA interactions such as DNase protection analysis or footprinting. Comparison of the spoVG and tycA nucleotide sequences in the regions where AbrB binds shows homology at several locations that contain an abundance of adenine and thymine residues. A region at -64 and -54 of spoVG (TTTTTCAAAAA, which lies within the UAS and contains the mutation site of spoVG42), is identified as a potential target for AbrB binding. The leader region of the tycA gene contains sequences of repeated GAAAA, a sequence that has been suggested as a site important for AbrB interaction (47) .
These studies provide evidence that is consistent with the idea that AbrB can serve as a repressor of gene transcription by directly binding to the transcription initiation region, thereby impairing the interaction between RNA polymerase and promoter DNA. This interaction would seem to be independent of the form of RNA polymerase that utilizes the promoter, as the spoVG promoter is recognized by the 0.H -j --<t4 form of holoenzyme, whereas the tycA promoter is probably utilized by the aA holoenzyme. In the case of spoVG, the site of AbrB interaction includes the UAS (36) . This region is similar to UASs that are associated with powerful promoters such as those of ribosomal RNA operons (37) . If this region stimulates transcription through a direct interaction with RNA polymerase, then one could imagine that this interaction would be disrupted when AbrB is bound. Another possible mechanism relates to the finding that A+T-rich sequences impart curvature in the axis of the DNA helix (38, 39) and that this, somehow, exerts a stimulatory effect on transcription initiation (40) . AbrB could alter the conformation of the UAS, perhaps by reducing DNA curvature, in such a way as to render the UAS incapable of enhancing transcription initiation. In the case of tycA, AbrB binds to a sequence that is spatially separated from the region of RNA polymerase-promoter interaction. It is now well established that several transcriptional repressors in prokaryotes can exert their effect on initiation from a distance (41) (42) (43) . AbrB protein also interacts with DNA near the tycA promoter region, which raises the possibility that two AbrB-DNA complexes repress transcription by interacting with one another. Such "communication" between DNA-repressor complexes in prokaryotes has been demonstrated (44) (45) (46) .
The abrB gene product is but one of several factors that regulate B. subtilis genes that are induced in the transition stage when exponential growth ends and stationary phase begins. Cells of an abrB mutant sporulate normally, and the stationary phase induction of spoVG and aprE appear to be unaltered by an abrB mutation (5, 8) . It has been proposed that AbrB represses vegetative phase expression of these genes, but, since there is little change in the pattern of expression in an abrB mutant, there probably exist other mechanisms for ensuring that stationary phase-induced genes remain repressed during vegetative growth. In contrast, tycA transcription appears to be regulated principally by spoOA and abrB, as evidenced by the constitutive expression of a tycA-IacZ fusion in an abrB mutant (3). This suggests that there are a collection ofgenes in B. subtilis that are repressed in vegetative phase solely through an abrB-dependent mechanism. The promoters of several of these genes have recently been identified. 11 It is through the study ofthese genes and the continued examination of AbrB-promoter interactions that the involvement of abrB in the regulation of gene transcription and in the developmental cycle ofB. subtilis can be better understood.
